Onconic Therapeutics, Inc. financial statements
Onconic Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | KRW 53.39B | EODHD |
| Net income | KRW 15.78B | EODHD |
| Cash and equivalents | KRW 47.05B | EODHD |
Onconic Therapeutics, Inc. financials on 6ix · Onconic Therapeutics, Inc. on 6ix